Floatz logo

Therapeutic Asset Ratings

141 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Denosumab
Metastatic Cancer
Kelly Fitzgerald, MDP2CCC (54)
Gm-Csf
Metastatic Cancer
Rampart Health, L.L.C.P2CCC (54)
Panobinostat
Metastatic Cancer
Asan Medical CenterP2CCC (54)
VEMURAFENIB
Metastatic Cancer
Seoul National University Bundang HospitalP2CCC (54)
Adebelimab
Metastatic Cancer
Fudan UniversityP2CCC (51)
ag-120
Metastatic Cancer
Fudan UniversityP2CCC (51)
Apalutamide
Metastatic Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCSP2CCC (51)
DALPICICLIB ISETIONATE
Metastatic Cancer
Fudan UniversityP2CCC (51)
e7 tcr-t cells
Metastatic Cancer
Christian HinrichsP2CCC (51)
FFNP
Metastatic Cancer
University of Wisconsin, MadisonP2CCC (51)
ose2101
Metastatic Cancer
GERCOR - Multidisciplinary Oncology Cooperative GroupP2CCC (51)
Ptvg-Ar
Metastatic Cancer
University of Wisconsin, MadisonP2CCC (51)
Ptvg-Hp
Metastatic Cancer
University of Wisconsin, MadisonP2CCC (51)
Rhgm-Csf
Metastatic Cancer
University of Wisconsin, MadisonP2CCC (51)
Zanzalintinib
Metastatic Cancer
Kelly Fitzgerald, MDP2CCC (51)
rc48-adc
Metastatic Cancer
BeOne MedicinesP1/2CCC (51)
TIL
Metastatic Cancer
City of Hope Medical CenterP1/2CCC (51)
Avelumab
Metastatic Cancer
Aulos Bioscience, Inc.P1/2CCC (48)
IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN MONOCLONAL REGN2810 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN2810 .KAPPA.-CHAIN, DIMER
Metastatic Cancer
OncoResponse, Inc.P1/2CCC (48)
Onapristone
Metastatic Cancer
University of Wisconsin, MadisonP2CC (46)
Avutometinib
Metastatic Cancer
Verastem, Inc.P1/2CC (46)
MERCAPTOPURINE ANHYDROUS
Metastatic Cancer
Kristoffer RohrbergP1/2CC (46)
THIOGUANINE ANHYDROUS
Metastatic Cancer
Kristoffer RohrbergP1/2CC (46)
[177lu]lu-sn201
Metastatic Cancer
Spago Nanomedical ABP1/2CC (43)
au-007
Metastatic Cancer
Aulos Bioscience, Inc.P1/2CC (43)
Showing 51 to 75 of 141 assets
PreviousPage 3 of 6Next